Header Logo

Oren Schaefer

Concepts (63)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pneumonia
2
2005
272
0.220
Why?
Suppuration
1
2003
10
0.220
Why?
Mycobacterium avium Complex
1
2003
3
0.220
Why?
Mycobacterium avium-intracellulare Infection
1
2003
8
0.210
Why?
Respiratory Tract Infections
1
2003
79
0.200
Why?
Bacterial Infections
1
2003
137
0.190
Why?
Cough
1
2003
183
0.180
Why?
Angioedemas, Hereditary
1
2010
5
0.090
Why?
Complement C1 Inhibitor Protein
1
2010
6
0.090
Why?
Complement Inactivating Agents
1
2010
13
0.090
Why?
Severity of Illness Index
2
2005
1470
0.080
Why?
Mianserin
1
2005
3
0.060
Why?
Oxazolidinones
1
2005
14
0.060
Why?
Serotonin Syndrome
1
2005
9
0.060
Why?
Acetamides
1
2005
13
0.060
Why?
Citalopram
1
2005
18
0.060
Why?
Triage
1
2005
111
0.060
Why?
Urticaria
1
2004
7
0.060
Why?
Antidepressive Agents
1
2005
230
0.060
Why?
Hypothermia, Induced
1
2004
41
0.060
Why?
Cold Temperature
1
2004
51
0.050
Why?
Patient Admission
1
2005
184
0.050
Why?
Immunocompetence
1
2003
21
0.050
Why?
Bronchoscopy
1
2003
79
0.050
Why?
Aortic Valve
1
2004
172
0.050
Why?
Coronary Artery Bypass
1
2004
276
0.050
Why?
Heart Valve Prosthesis Implantation
1
2004
157
0.050
Why?
Intensive Care Units
1
2005
454
0.050
Why?
Radiography
1
2003
514
0.050
Why?
Diagnosis, Differential
1
2003
910
0.040
Why?
Middle Aged
4
2005
16539
0.040
Why?
Chronic Disease
1
2003
744
0.040
Why?
Anti-Bacterial Agents
1
2005
735
0.040
Why?
Female
5
2010
31223
0.040
Why?
Adult
3
2010
15981
0.030
Why?
Aged
3
2005
13575
0.030
Why?
Humans
6
2010
60093
0.030
Why?
Male
4
2010
27959
0.020
Why?
Adolescent
1
2003
5956
0.020
Why?
Retrospective Studies
1
2003
6136
0.020
Why?
Ultrafiltration
1
2010
11
0.020
Why?
Cross-Over Studies
1
2010
144
0.020
Why?
Infusions, Intravenous
1
2010
170
0.020
Why?
Nanotechnology
1
2010
129
0.020
Why?
Analysis of Variance
1
2010
576
0.020
Why?
Proportional Hazards Models
1
2010
679
0.020
Why?
Double-Blind Method
1
2010
680
0.020
Why?
Acute Disease
1
2010
661
0.020
Why?
Linezolid
1
2005
7
0.020
Why?
Protein Synthesis Inhibitors
1
2005
25
0.020
Why?
Drug Synergism
1
2005
132
0.020
Why?
Bone Marrow Transplantation
1
2005
136
0.020
Why?
Transplantation, Homologous
1
2005
236
0.020
Why?
Urinary Tract Infections
1
2005
79
0.010
Why?
Community-Acquired Infections
1
2005
88
0.010
Why?
Rewarming
1
2004
7
0.010
Why?
Leukemia, Myeloid, Acute
1
2005
170
0.010
Why?
Sensitivity and Specificity
1
2005
1100
0.010
Why?
Pilot Projects
1
2005
930
0.010
Why?
Child
1
2010
4331
0.010
Why?
Risk Assessment
1
2005
1934
0.010
Why?
Aged, 80 and over
1
2005
5192
0.010
Why?
United States
1
2005
7608
0.010
Why?
Schaefer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (63)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_